텍사스의 여포성 림프종 임상 시험
여포성 림프종 관련 연구 35개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.
텍사스의 도시
공식 연구 텍스트(영어)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Md Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05006716A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NEXT Dallas, Irving
- NEXT Oncology, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT03460977A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Texas Oncology - DFW (Sammons CC), Dallas
- Baylor College of Medicine, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- University of Texas Southwestern, Dallas
- MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Baylor Scott & White Research Institute, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Austin
- Research Site, Lubbock
- Research Site, Shenandoah
- 외 1개
피험자 모집 중3상
18세 ~ 130세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06549595NEO100 and High-Grade Meningioma
- Baylor Scott and White, Dallas
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT05023018Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Austin
- Research Site, Houston
- Research Site, San Antonio
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Texas Oncology, Dallas
피험자 모집 중3상
12세 ~ 100세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Center for Oncology and Blood Disorders, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06091254A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
- MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06043323A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
- Research Site, San Antonio
피험자 모집 중1상건강한 지원자 환영
18세 ~ 85세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07546760Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
- M D Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT06108232SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Texas Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
- University of Texas Health Mays Cancer Center, San Antonio
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT05303519Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Baylor University Medical Center, Dallas
- Texas Transplant Institute, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT05826535A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06542250Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
- Natera, Inc., Austin
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07750886Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
13세 ~ 90세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06533579A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- The University of TX MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07424833Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
- Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston
- The University of Texas Health Science at San Antonio, San Antonio
피험자 모집 중2상
18세 ~ 55세 · 모든 성별 · 2026. 7. 15. 업데이트됨 · NCT05951777A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT05131022A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Texas Liver Institute - American Research Corporation, San Antonio
- Pinnacle Clinical Research, San Antonio
피험자 모집 중1상
18세 ~ 80세 · 모든 성별 · 2026. 6. 16. 업데이트됨 · NCT07559474Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
피험자 모집 중관찰 연구
0세 ~ 38세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT06131801A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Texas Oncology - Central/South Texas, Austin
- Local Institution - 0212, Fort Worth
- Local Institution - 0230, San Antonio
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 20. 업데이트됨 · NCT06911502The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
피험자 모집 중1/2상
12세 ~ 95세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04329728A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 20. 업데이트됨 · NCT04830137Study of SGR-1505 in Mature B-Cell Neoplasms
- University of Texas Southwestern, Dallas
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT05544019Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
- University of Texas Medical Branch at Galveston, TX, Galveston
피험자 모집 중
50세 이상 · 여성 · 2026. 2. 11. 업데이트됨 · NCT07206121Cognitive Screening Made Easy for PCPs - Administrative Supplement
- Family Wellness Clinic, Austin
- University of Texas Health Austin Primary Care Clinic, Austin
- UT Health San Antonio's Geriatrics and Supportive Care Clinic, San Antonio
피험자 모집 중건강한 지원자 환영
60세 이상 · 모든 성별 · 2026. 2. 5. 업데이트됨 · NCT06928298AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Oncology Consultants, Houston
- University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 12. 10. 업데이트됨 · NCT05602363A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- SCRI, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 11. 14. 업데이트됨 · NCT05643742SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- University of Texas Southwestern Medical Center, Dallas
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 10. 2. 업데이트됨 · NCT05780034Phosphatidylethanol and Other Ethanol Consumption Markers
- University of North Texas, Denton
- University of Texas Health Science Center San Antonio, San Antonio
피험자 모집 중건강한 지원자 환영
21세 이상 · 모든 성별 · 2025. 5. 13. 업데이트됨 · NCT06747364Paper-Based and Smartphone-Based Memory Supports
- UT Health Austin Comprehensive Memory Center, Austin
- Baylor Scott & White Healthcare, Temple
- Baylor University, Waco
피험자 모집 중
50세 이상 · 모든 성별 · 2024. 7. 9. 업데이트됨 · NCT06444841ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.